Skip to main content
Home U.S.- CHINA | ECONOMIC and SECURITY REVIEW COMMISSION

U.S.-China Economic AND Security Review Commission

  • About Us
    hearings navigation
    About the Commission

    The U.S.-China Economic and Security Review Commission is a legislative branch commission created by the United States Congress in October 2000 with the legislative mandate to monitor, investigate, and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.

    About the Commission
    • Charter
    • Commission Members
    • Commission Staff
    • Job Opportunities
    • Contact Us
  • Annual Reports
  • Recommendations
  • Hearings
  • Research
    research navigation menu drop down
    Research

    The U.S.-China Economic and Security Review Commission is chartered to monitor, investigate, and report to Congress on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China. The Commission meets its research mission by submitting to Congress an Annual Report, as well as by conducting staff-led reports, contracted research, and more.

    View All Research
    • RESEARCH BY TOPIC
      Censorship and Control RESEARCH BY TOPIC
    • China’s Economy and Resources
    • Compliance with International Rules and Norms
    • Finance and Investment
    • Global Relations and Influence
    • Hong Kong
    • Product Safety
    • Science and Technology
    • Security and Defense
    • Taiwan
    • Trade and Supply Chains
    • FEATURED RESEARCH
      Chinese Companies Listed on Major U.S. Stock Exchanges FEATURED RESEARCH
    • PRC in International Organizations
    • China-Ukraine Timeline

Search

Search Results

China Bulletin
01/07/2020
January 2020 Trade Bulletin
In Focus – Index Inclusions Increase Foreign Holdings of Chinese Securities
China Bulletin
12/05/2019
December 2019 Trade Bulletin
In focus – Chinese telecom operators launch 5G services
Annual Report
11/14/2019
2019 Annual Report to Congress

The 2019 Annual Report to Congress covers an array of topics including U.S.-China trade tensions, U.S. reliance on Chinese pharmaceuticals, China's global military ambitions, and U.S.-China competition in critical emerging technologies.

Research
11/08/2019
Request for Proposals on Developments in China’s Military and Dual-Use Logistics Capabilities

The U.S.-China Economic and Security Review Commission  invites submission of proposals to provide a one-time unclassified report on developments in China’s military and dual-use logistics capabilities to support expeditionary operations beyond China’s borders.

China Bulletin
11/05/2019
November 2019 Trade Bulletin
Quarterly review of China’s economy
China Bulletin
10/09/2019
October 2019 Trade Bulletin
In focus – China’s pork supply
China Bulletin
09/10/2019
September 2019 Trade Bulletin
In focus – China’s surveillance technology
Hearings
09/04/2019
U.S.-China Relations in 2019: A Year in Review
The hearing will review key developments in the U.S.-China relationship in 2019. Panel 1 will evaluate developments in China’s political economy and the impact of U.S.-China trade frictions on the Chinese economy. Panel 2 will assess the implications of Chinese military activities and modernization in 2019 for the United States and U.S. allies and partners. Panel 3 will review the implications of economic, political, and security developments between China and Taiwan for regional security, and explore the escalating situation in Hong Kong.
China Bulletin
08/05/2019
August 2019 Trade Bulletin
Quarterly review of China’s economy
Hearings
07/31/2019
Exploring the Growing U.S. Reliance on China's Biotech and Pharmaceutical Products
The hearing will assess China’s role in global health, pharmaceuticals, and medical products. In addition, it will examine the activities of Chinese health and biotech firms in the United States, and U.S. access to China’s health market. Finally, the hearing will consider the implications for U.S. public health and national security of growing U.S. dependence on Chinese health products.

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Next page ››
  • Last page Last »

Subscribe To Our Mailing List

CAPTCHA

U.S.-CHINA

U.S.-China Economic and
Security Review Commission

444 North Capitol Street NW, Suite 602
Washington, DC 20001

202-624-1407linkedintwitter

Footer menu

  • Contact Us
  • All Announcements
  • Privacy
  • Accessibility